既往分类为WHO I级的脑膜瘤中显微镜下脑侵犯与患者结局无关
该回顾性双中心队列纳入875例成人颅内WHO I级脑膜瘤患者,其中28例组织学确认脑侵犯,中位随访73个月。单因素和多因素分析显示全切除对无进展生存有利(p<0.001,HR 0.237,CI 0.170-0.382),而脑侵犯的存在对无进展生存无显著影响(p=0.787,HR 0.852,CI 0.268-2.710)。作者结论认为在可获得脑/脑膜瘤交界组织学标本时脑侵犯常见(16.5%),但未影响早期复发。
要点
- 全切除对无进展生存有利(p<0.001,HR 0.237,CI 0.170-0.382)。
- 脑侵犯对无进展生存无显著影响(p=0.787,HR 0.852,CI 0.268-2.710)。
- 有脑侵犯者更可能接受放疗(p=0.03),但未放疗亚组中脑侵犯仍无预后影响(p=0.749,HR 0.772,CI 0.158-3.767)。
核心结论
- 在可获得脑/脑膜瘤交界组织学标本的WHO I级脑膜瘤中,脑侵犯常见(16.5%),但脑侵犯未影响早期复发。
研究设计与样本
- 回顾性分析两个神经外科连续收治的成人颅内WHO I级(±脑侵犯)脑膜瘤患者,共875例,其中28例组织学确认脑侵犯,中位随访73个月。
主要发现
- 单因素和多因素模型中,全切除对无进展生存有有利的预后影响(p<0.001,HR 0.237,CI 0.170-0.382)。
- 170例组织病理标本中存在脑/脑膜瘤交界者作为亚组单独分析,脑侵犯的存在对无进展生存未达统计学显著(p=0.787,HR 0.852,CI 0.268-2.710)。
- 在可获取脑/脑膜瘤交界标本的亚组中,脑侵犯对无进展生存仍未达统计学显著(p=0.811,HR 0.848,CI 0.222-3.246)。
- 有脑侵犯与无脑侵犯的患者在年龄、肿瘤位置和切除范围上无差异,但有脑侵犯者更可能接受放疗(p=0.03)。
- 未放疗肿瘤的亚组分析显示脑侵犯无预后影响(p=0.749,HR 0.772,CI 0.158-3.767)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: For meningiomas, the 2016 revision of the WHO classification introduced brain invasion per se as a sufficient condition to classify as grade II. We analyzed whether meningiomas previously graded as WHO grade I differ in prognosis depending on the presence of microscopic brain invasion. METHODS: A consecutive series of patients with intracranial meningioma WHO grade I (± brain invasion) at two neurosurgical departments was analyzed retrospectively. Cox regression models on progression-free survival (PFS) and Kaplan-Meier survival estimates were performed. RESULTS: 875 adult patients were included. Histological diagnosis of brain invasion was confirmed in 28 patients. Median follow-up was 73 months. In univariate and multivariate models, gross total resection gained favorable prognostic influence for PFS (p < 0.001, HR: 0.237, CI 0.170-0.382). 170 patients with the brain/meningioma interface present in histopathological specimen were separately analyzed as a subgroup. Importantly, presence of brain invasion did not reach significance for PFS, even in the subgroup with available specimen of brain/meningioma interface (p = 0.787, HR: 0.852, CI 0.268-2.710 and p = 0.811, HR: 0.848, CI 0.222-3.246, respectively). Patients with and without brain invasion did not differ in terms of age, tumor location and extent of resection, but were more likely to receive radiotherapy (p = 0.03) of tumor remnants. However, subgroup analysis of non-irradiated tumors revealed no prognostic influence of brain invasion (p = 0.749, HR: 0.772, CI 0.158-3.767). CONCLUSIONS: In this bi-institutional series, brain invasion was frequent among meningiomas WHO grade I when brain/meningioma interface was available for histology (16.5%). However, brain invasion did not impact early recurrence.
引用
- Biczok A, Jungk C, Egensperger R, et al. Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome. J Neurooncol. 2019. PMID: 31713016. doi:10.1007/s11060-019-03312-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。